IL98177A0 - Synergistic compositions containing tgf-beta - Google Patents

Synergistic compositions containing tgf-beta

Info

Publication number
IL98177A0
IL98177A0 IL98177A IL9817791A IL98177A0 IL 98177 A0 IL98177 A0 IL 98177A0 IL 98177 A IL98177 A IL 98177A IL 9817791 A IL9817791 A IL 9817791A IL 98177 A0 IL98177 A0 IL 98177A0
Authority
IL
Israel
Prior art keywords
beta
compositions containing
synergistic compositions
containing tgf
tgf
Prior art date
Application number
IL98177A
Other languages
English (en)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of IL98177A0 publication Critical patent/IL98177A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1841—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IL98177A 1990-05-22 1991-05-17 Synergistic compositions containing tgf-beta IL98177A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/527,215 US5147854A (en) 1990-05-22 1990-05-22 Tgf-b compositions and method

Publications (1)

Publication Number Publication Date
IL98177A0 true IL98177A0 (en) 1992-06-21

Family

ID=24100576

Family Applications (1)

Application Number Title Priority Date Filing Date
IL98177A IL98177A0 (en) 1990-05-22 1991-05-17 Synergistic compositions containing tgf-beta

Country Status (16)

Country Link
US (1) US5147854A (no)
EP (1) EP0462398A1 (no)
JP (1) JPH05213772A (no)
KR (1) KR910019638A (no)
AU (1) AU636489B2 (no)
CA (1) CA2042973A1 (no)
FI (1) FI912462A (no)
HU (1) HUT57599A (no)
IE (1) IE911736A1 (no)
IL (1) IL98177A0 (no)
MC (1) MC2259A1 (no)
NO (1) NO911949L (no)
NZ (1) NZ238179A (no)
PT (1) PT97728A (no)
YU (1) YU89891A (no)
ZA (1) ZA913647B (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5248666A (en) * 1984-03-23 1993-09-28 Oncogen Methods for inhibiting neoplastic cell proliferation using platelet factor 4
US4890152A (en) * 1986-02-14 1989-12-26 Matsushita Electric Works, Ltd. Plastic molded chip carrier package and method of fabricating the same
US5824297A (en) * 1990-06-25 1998-10-20 Oncogene Science, Inc. Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof
GB9106678D0 (en) * 1991-03-28 1991-05-15 Ferguson Mark W J Wound healing
US5817625A (en) * 1992-09-21 1998-10-06 Oncogene Science, Inc. Methods of prevention of oral mucositis with transforming growth factor beta
US5726058A (en) * 1992-12-01 1998-03-10 Jalkanen; Markku Syndecan stimulation of cellular differentiation
ES2154290T3 (es) * 1992-12-01 2001-04-01 Biotie Therapies Corp Estimulacion de la diferenciacion celular por sindecano.
DE4304394A1 (en) * 1993-02-13 1993-09-02 Fresenius Ag Prepn. for nourishment of oncological patients - comprises fats formulation contg. oleic acid, alpha-linolenic acid, etc., and opt. carbohydrate and proteins
US6017727A (en) * 1994-03-07 2000-01-25 Biotie Therapies Ltd. Syndecan enhancer element and syndecan stimulation of cellular differentiation
US6077828A (en) 1996-04-25 2000-06-20 Abbott Laboratories Method for the prevention and treatment of cachexia and anorexia
WO1998004680A1 (en) * 1996-07-26 1998-02-05 University Of Manitoba Serum-free medium for growth of anchorage-dependant mammalian cells
DE19646392A1 (de) * 1996-11-11 1998-05-14 Lohmann Therapie Syst Lts Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
US20020141995A1 (en) * 1997-06-10 2002-10-03 Irvin Charles G. Method for treatment of inflammatory disease
US6248723B1 (en) 1997-06-10 2001-06-19 National Jewish Medical And Research Center Method for treatment of inflammatory disease
US5891925A (en) * 1997-06-27 1999-04-06 Abbott Laboratories Diagnostic method for assessing the serum cholesterol response to low diets
AU6232899A (en) * 1999-10-06 2001-05-10 Campina Melkunie B.V. Use of transforming growth factor beta and growth factors in the treatment and prevention of diseases of the intestinal mucosa
US6767541B2 (en) * 2000-03-20 2004-07-27 The Regents Of The University Of California HER-2/neu overexpression abrogates growth inhibitory pathways
US6689810B2 (en) * 2001-08-21 2004-02-10 Cellular Sciences, Inc. Method for treating pulmonary disease states in mammals by altering indigenous in vivo levels of nitric oxide
US20040229791A1 (en) * 2002-12-31 2004-11-18 Jung San Huang Compositions and methods of modulating TGF-beta activity by fatty acids
CA2436650A1 (en) * 2003-08-06 2005-02-06 Naturia Inc. Conjugated linolenic acid (clnatm) compositions: synthesis, purification and uses
US20060186078A1 (en) * 2005-02-22 2006-08-24 David Ziegenhorn Screw on dispensing closure with structure for preventing removal
ES2264886B1 (es) * 2005-05-12 2008-02-01 Proyecto Empresarial Brudy, S.L. Utilizacion de acido docosahexaenoico para el tratamiento de enfermedades tumorales.
GB0704678D0 (en) 2007-03-09 2007-04-18 Univ Bristol Pro- and anti-angiogenic treatments
US8946201B2 (en) * 2007-08-27 2015-02-03 Saint Louis University Methods for inhibiting TGF-β
JP5629947B2 (ja) * 2008-06-10 2014-11-26 ディーエスエム アイピー アセッツ ビー．ブイ． 植物抽出物およびｐｕｆａの組合せ
WO2010033507A1 (en) * 2008-09-16 2010-03-25 St. Louis University Method of enhancing tgf-beta signalling
WO2014130411A1 (en) * 2013-02-22 2014-08-28 Emory University Tgf-beta enhancing compositions for cartilage repair and methods related thereto

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4326055A (en) * 1977-12-22 1982-04-20 Hoffmann-La Roche Inc. Stilbene derivatives
CA1275922C (en) * 1985-11-28 1990-11-06 Harunobu Amagase Treatment of cancer
US4929442A (en) * 1986-09-26 1990-05-29 Exovir, Inc. Compositions suitable for human topical application including a growth factor and/or related materials
US4816442A (en) * 1986-11-07 1989-03-28 Collagen Corporation Method of inhibiting tumor growth sensitive to CIF-βtreatment

Also Published As

Publication number Publication date
US5147854A (en) 1992-09-15
AU7713991A (en) 1991-12-12
YU89891A (sh) 1994-06-10
EP0462398A1 (en) 1991-12-27
MC2259A1 (fr) 1993-04-26
AU636489B2 (en) 1993-04-29
ZA913647B (en) 1992-02-26
KR910019638A (ko) 1991-12-19
FI912462A0 (fi) 1991-05-21
IE911736A1 (en) 1991-12-04
FI912462A (fi) 1991-11-23
HU911672D0 (en) 1991-11-28
NZ238179A (en) 1993-04-28
CA2042973A1 (en) 1991-11-23
PT97728A (pt) 1992-02-28
HUT57599A (en) 1991-12-30
NO911949L (no) 1991-11-25
NO911949D0 (no) 1991-05-21
JPH05213772A (ja) 1993-08-24

Similar Documents

Publication Publication Date Title
IL98177A0 (en) Synergistic compositions containing tgf-beta
GB9024496D0 (en) Antimicrobial compositions
GB9102579D0 (en) Compositions
GB9005856D0 (en) Compositions
IL98463A0 (en) Synergistic antimalarial composition containing benflumetol
ZA92342B (en) Lice-repellant compositions
GB9015822D0 (en) Compositions
GB9114099D0 (en) Compositions
GB9015892D0 (en) Compositions
GB9101592D0 (en) Compositions
GB9101655D0 (en) Compositions
EP0452632A3 (en) Dichloro-pentafluoropropanes-containing compositions
GB9004832D0 (en) Compositions
GB9101654D0 (en) Compositions
GB9006022D0 (en) Synergistic compositions
HU900262D0 (en) Oralhygenic compositions
IE904436L (en) Sterilizing compositions
IE901217L (en) Synergistic compositions containing ketanserin
GB9010807D0 (en) Compositions
IE900954L (en) Compositions
GB9012300D0 (en) Compositions
GB9013805D0 (en) Siloxane-polyester compositions
GB9014709D0 (en) Compositions
GB9014768D0 (en) Compositions
GB9014941D0 (en) Compositions